4781 - 4790 of 6230 Results
Title
Year
- Differential Associations of Apolipoprotein E ε4 Genotype With Attentional Abilities Across the Life Span of Individuals With Down Syndrome2020OPENTitle: Differential Associations of Apolipoprotein E ε4 Genotype With Attentional Abilities Across the Life Span of Individuals With Down SyndromeJournal Name: JAMA Network OpenPublisher: American Medical Association (AMA)Vol: 3Issue #: 9Start Page: e2018221End Page: e2018221Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamanetworkopen.2020.18221Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2770878/dsouza_2020_oi_200657_1605807465.21177.pdfCitation Count: 9
-
OPENTitle: Freezing of Gait and Its Levodopa ParadoxJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 77Issue #: 3Start Page: 287End Page: 287Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2019.4006Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2757501/jamaneurology_nonnekes_2019_vp_190017.pdfCitation Count: 49
-
OPENTitle: Safety and Efficacy of RimabotulinumtoxinB for Treatment of Sialorrhea in AdultsJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 77Issue #: 4Start Page: 461End Page: 461Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1001/jamaneurol.2019.4565Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2758316/jamaneurology_isaacson_2020_oi_190108.pdfCitation Count: 57
- Seven-Year Experience From the National Institute of Neurological Disorders and Stroke–Supported Network for Excellence in Neuroscience Clinical Trials2020OPENTitle: Seven-Year Experience From the National Institute of Neurological Disorders and Stroke–Supported Network for Excellence in Neuroscience Clinical TrialsJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 77Issue #: 6Start Page: 755End Page: 755Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2020.0367Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7483960Citation Count: 8
- Evaluating the Use of Circulating MicroRNA Profiles for Lung Cancer Detection in Symptomatic Patients2020OPENTitle: Evaluating the Use of Circulating MicroRNA Profiles for Lung Cancer Detection in Symptomatic PatientsJournal Name: JAMA OncologyPublisher: American Medical Association (AMA)Vol: 6Issue #: 5Start Page: 714End Page: 714Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaoncol.2020.0001Best OA location URL: https://jamanetwork.com/journals/jamaoncology/articlepdf/2761984/jamaoncology_fehlmann_2020_oi_200001.pdfCitation Count: 115
- Greater intraindividual variability in neuropsychological performance predicts cognitive impairment in de novo Parkinson’s disease.2019OPENTitle: Greater intraindividual variability in neuropsychological performance predicts cognitive impairment in de novo Parkinson’s disease.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 34Issue #: 1Start Page: 24End Page: 30Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1037/neu0000577Best OA location URL: http://psycnet.apa.org/journals/neu/34/1/24.pdfCitation Count: 20
-
OPENTitle: Topography of Cholinergic Changes in Dementia With Lewy Bodies and Key Neural Network HubsJournal Name: The Journal of Neuropsychiatry and Clinical NeurosciencesPublisher: American Psychiatric Association PublishingVol: 32Issue #: 4Start Page: 370End Page: 375Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1176/appi.neuropsych.19070165Best OA location URL: https://neuro.psychiatryonline.org/doi/pdf/10.1176/appi.neuropsych.19070165Citation Count: 24
- Ursodeoxycholic acid as a novel disease-modifying treatment for Parkinson’s disease: protocol for a two-centre, randomised, double-blind, placebo-controlled trial, The 'UP' study2020OPENTitle: Ursodeoxycholic acid as a novel disease-modifying treatment for Parkinson’s disease: protocol for a two-centre, randomised, double-blind, placebo-controlled trial, The 'UP' studyJournal Name: BMJ OpenPublisher: BMJVol: 10Issue #: 8Start Page: e038911End Page: e038911Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1136/bmjopen-2020-038911Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/10/8/e038911.full.pdfCitation Count: 28
-
OPENTitle: Distinct dopaminergic abnormalities in traumatic brain injury and Parkinson’s diseaseJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 91Issue #: 6Start Page: 631End Page: 637Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2019-321759Citation Count: 14
-
OPENTitle: Commentary: Monochorea of the Upper Limb in a Patient with Spinocerebellar Ataxia Type 12Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13290Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13290Citation Count: 1